168 related articles for article (PubMed ID: 2580711)
1. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
Friedmann W; Steffens J; Lobeck H; Blümcke S; Nagel R
Eur Urol; 1985; 11(1):52-6. PubMed ID: 2580711
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical demonstration of tumor-associated antigens in urinary bladder carcinomas using mono- and polyclonal antisera].
Friedmann W; Steffens J; Lobeck H
Onkologie; 1985 Apr; 8(2):105-10. PubMed ID: 2582324
[TBL] [Abstract][Full Text] [Related]
3. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
Shah NT; Tuttle SE; Strobel SL; Gandhi L
J Surg Oncol; 1985 Aug; 29(4):265-8. PubMed ID: 2417056
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
5. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
Ellis DW; Leffers S; Davies JS; Ng AB
Am J Clin Pathol; 1984 Mar; 81(3):279-84. PubMed ID: 6199966
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical diagnosis of the metastasizing prostatic carcinoma.
Steffens J; Friedmann W; Lobeck H
Eur Urol; 1985; 11(2):91-4. PubMed ID: 2408895
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical diagnosis of metastasizing prostatic carcinomas].
Friedmann W; Steffens J; Lobeck H
Onkologie; 1984 Dec; 7(6):337-41. PubMed ID: 6084838
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma of the prostate involving 2 cell types (prostate specific antigen producing and carcinoembryonic antigen producing) with selective metastatic spread.
Guthman DA; Farrow GM; Myers RP; Ferrigni RG; Lieber MM
J Urol; 1991 Sep; 146(3):854-6. PubMed ID: 1714970
[TBL] [Abstract][Full Text] [Related]
9. Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy.
Grignon D; Troster M
Prostate; 1985; 7(2):195-202. PubMed ID: 2413432
[TBL] [Abstract][Full Text] [Related]
10. Keratin, luminal epithelial antigen and carcinoembryonic antigen in human urinary bladder carcinomas. An immunohistochemical study.
Nathrath WB; Arnholdt H; Wilson PD
Pathol Res Pract; 1982; 175(2-3):299-307. PubMed ID: 6190152
[TBL] [Abstract][Full Text] [Related]
11. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.
Steffens J; Friedmann W; Lobeck H
Urol Res; 1985; 13(2):55-9. PubMed ID: 2409654
[TBL] [Abstract][Full Text] [Related]
13. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
[TBL] [Abstract][Full Text] [Related]
14. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
Mathieu MC; Caillaud JM
Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
Abrahamsson PA; Lilja H; Falkmer S; Wadström LB
Prostate; 1988; 12(1):39-46. PubMed ID: 2450341
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen as a marker of adenocarcinoma of prostate.
Kellokumpu-Lehtinen P; Nurmi M; Koskinen P; Irjala K
Urol Res; 1989; 17(4):245-9. PubMed ID: 2475959
[TBL] [Abstract][Full Text] [Related]
17. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.
Gallee MP; Visser-de Jong E; van der Korput JA; van der Kwast TH; ten Kate FJ; Schroeder FH; Trapman J
Urol Res; 1990; 18(3):181-7. PubMed ID: 1697709
[TBL] [Abstract][Full Text] [Related]
18. Three predominant prostatic proteins.
Abrahamsson PA; Lilja H
Andrologia; 1990; 22 Suppl 1():122-31. PubMed ID: 1720287
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical detection of prostate carcinoma].
Ma WX; Li W
Zhonghua Bing Li Xue Za Zhi; 1989 Mar; 18(1):37-9. PubMed ID: 2476252
[TBL] [Abstract][Full Text] [Related]
20. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]